| A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | Phase 2 | Children's Oncology Group | <1 mi |
| A Study of a Weight Loss Intervention in People With Endometrial Cancer | Early 1 | Memorial Sloan Kettering Cancer Center | <1 mi |
| A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) | Phase 1/2 | GI Innovation, Inc. | <1 mi |
| NYSCF Scientific Discovery Biobank | — | New York Stem Cell Foundation Research Institute | <1 mi |
| A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer | Phase 1 | Memorial Sloan Kettering Cancer Center | <1 mi |
| PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes | Phase 4 | Brigham and Women's Hospital | <1 mi |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Phase 3 | Boehringer Ingelheim | <1 mi |
| PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life | — | University of Colorado, Denver | <1 mi |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | Phase 1/2 | COUR Pharmaceutical Development Company, Inc. | <1 mi |
| Validating CGM for GDM | N/A | Icahn School of Medicine at Mount Sinai | <1 mi |
| Human Models of Selective Insulin Resistance: Alpelisib, Part I | Phase 1 | Columbia University | <1 mi |
| TrialNet Pathway to Prevention of T1D | — | University of South Florida | <1 mi |
| Real World Evidence Clinical Utility Study of KidneyIntelX | — | Renalytix AI, Inc. | <1 mi |
| A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes | Phase 2 | Zucara Therapeutics Inc. | <1 mi |
| A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events | N/A | Cleerly, Inc. | <1 mi |
| DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes | Phase 4 | Ohio State University | <1 mi |
| ED Diabetes Screening and Outpatient Care - Aim 3 | N/A | NYU Langone Health | <1 mi |
| Implementing an Effective Diabetes Intervention Among Low-Income Immigrants | N/A | NYU Langone Health | <1 mi |
| Bionic Pancreas in CFRD | Phase 3 | Jaeb Center for Health Research | <1 mi |
| DISCOVERY of Risk Factors for Type 2 Diabetes in Youth | — | George Washington University | <1 mi |
| Texts for Diabetes Control Among Homeless Persons | N/A | George Washington University | <1 mi |
| Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes | Phase 4 | VA Office of Research and Development | <1 mi |
| Pregnancy and Postpartum CGM in GDM | — | Icahn School of Medicine at Mount Sinai | <1 mi |
| Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease | Phase 2 | Pharming Technologies B.V. | <1 mi |
| A Study of GNTI-122 in Adults Recently Diagnosed With T1D | Phase 1 | GentiBio, Inc | <1 mi |
| Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels | Phase 1 | Michio Hirano, MD | <1 mi |
| Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) | N/A | Rutgers, The State University of New Jersey | <1 mi |
| HLA Demographics Study in Adults With Type 1 Diabetes | — | GentiBio, Inc | <1 mi |
| Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) | — | The Rogosin Institute | <1 mi |
| High Fructose Diet, the Gut Microbiome, and Metabolic Health | N/A | Icahn School of Medicine at Mount Sinai | <1 mi |
| Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing | N/A | Reprise Biomedical, Inc. | <1 mi |
| Cholesterol Lowering and Residual Risk in Diabetes, Type 1 | Phase 4 | NYU Langone Health | <1 mi |
| Graded Insulin Suppression Test P&F | Phase 1 | Columbia University | <1 mi |
| A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin | Phase 3 | Eli Lilly and Company | <1 mi |
| RESET System Pivotal Trial (Rev F) | N/A | Morphic Medical Inc. | <1 mi |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes | Phase 3 | Sanofi | <1 mi |
| Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes | Phase 2/3 | Jaeb Center for Health Research | <1 mi |
| Lifestyle Patterns and Glycemic Control | N/A | Columbia University | <1 mi |
| North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) | — | Columbia University | <1 mi |
| Rare and Atypical Diabetes Network | — | University of South Florida | <1 mi |
| Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) | — | Jaeb Center for Health Research | <1 mi |
| CGM for the Early Detection and Management of Hyperglycemia in Pregnancy | N/A | Jaeb Center for Health Research | <1 mi |
| Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes | Phase 3 | Kailera | <1 mi |
| Transformative Research in Diabetic Nephropathy | — | University of Pennsylvania | <1 mi |
| LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes | N/A | NYU Langone Health | <1 mi |
| CHIME: Comparing Health Interventions for Maternal Equity | N/A | Stanford University | <1 mi |
| Long-Term Outcomes of Teplizumab in Routine Clinical Care | — | Sanofi | <1 mi |
| Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus | Phase 2 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | <1 mi |
| Effect of Insulin Lowering on Lipogenesis | Phase 1 | Columbia University | <1 mi |
| Kidney Precision Medicine Project | — | Icahn School of Medicine at Mount Sinai | <1 mi |
| Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study | — | Indiana University | <1 mi |
| Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes | N/A | Insulet Corporation | <1 mi |
| Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers | N/A | Reprise Biomedical, Inc. | <1 mi |
| A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity | Phase 3 | Pfizer | <1 mi |
| Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG | Phase 2 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | <1 mi |
| A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes | Phase 3 | Novo Nordisk A/S | <1 mi |
| APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life | N/A | Weill Medical College of Cornell University | <1 mi |
| App-Based Certified Diabetes Education Therapy (AB-CDE) | N/A | Oregon Health and Science University | <1 mi |
| Alpelisib Challenge Test (ACT) | Phase 1 | Columbia University | <1 mi |
| AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications | Phase 3 | Novo Nordisk A/S | <1 mi |
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide | Phase 2 | Eli Lilly and Company | 4 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes | Phase 3 | Eli Lilly and Company | 4 mi |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM | Phase 3 | AstraZeneca | 4 mi |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) | Phase 2/3 | CSL Behring | 4 mi |
| A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | 4 mi |
| A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes | Phase 3 | Ascletis Pharma (China) Co., Limited | 4 mi |
| Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health. | — | Clindove Research LLC | 5 mi |
| Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility | — | Brooklyn Clinical Research | 5 mi |
| A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus | Phase 2 | Corxel Pharmaceuticals | 5 mi |
| A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | 5 mi |
| A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar | Phase 3 | Boehringer Ingelheim | 5 mi |
| A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) | Phase 3 | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 5 mi |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin | Phase 3 | AstraZeneca | 5 mi |
| Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy | — | iHealthScreen Inc | 9 mi |
| Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema | Phase 2/3 | AbbVie | 11 mi |
| A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004) | Phase 3 | Merck Sharp & Dohme LLC | 11 mi |
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease | Phase 3 | Alessandro Doria | 12 mi |
| Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease | Phase 2 | Regeneron Pharmaceuticals | 12 mi |
| Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression | N/A | Albert Einstein College of Medicine | 12 mi |
| Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes | N/A | Boston Medical Center | 12 mi |
| Regulation of Endogenous Glucose Production by Central KATP Channels | Phase 2 | Albert Einstein College of Medicine | 12 mi |
| Fresh Takes!: An Evaluation of the Impact of Receiving Fresh Food Boxes | N/A | Montefiore Medical Center | 12 mi |
| Milk for Diabetes Prevention | N/A | Albert Einstein College of Medicine | 12 mi |
| SPARK-CGM Implementation | N/A | Montefiore Medical Center | 12 mi |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin | Phase 3 | AstraZeneca | 12 mi |
| Registry for Stage 2 Type 1 Diabetes | — | Sanofi | 13 mi |
| Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers | N/A | Piomic Medical | 16 mi |
| DFC 004 Biomarkers for Active Diabetic Foot Ulcers | — | University of Michigan | 16 mi |
| Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial | N/A | Sonavex, Inc. | 17 mi |
| Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers | Phase 1/2 | Eluciderm Inc | 17 mi |
| Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge | N/A | NYU Langone Health | 19 mi |
| Exercise and Intranasal Insulin in Type 2 Diabetes | Phase 2/3 | Rutgers, The State University of New Jersey | 25 mi |
| Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer | Phase 1/2 | Aulos Bioscience, Inc. | 26 mi |
| CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations | N/A | Capsicure, LLC | 28 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes | Phase 3 | Eli Lilly and Company | 28 mi |
| Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients | N/A | Rutgers, The State University of New Jersey | 28 mi |
| Extracellular Vesicles, Insulin Action, and Exercise | N/A | Rutgers, The State University of New Jersey | 28 mi |
| Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy | N/A | Rutgers, The State University of New Jersey | 28 mi |
| A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus | Phase 3 | AstraZeneca | 29 mi |
| Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes | Phase 3 | Kailera | 34 mi |
| A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight | Phase 2 | Eli Lilly and Company | 34 mi |
| A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus | — | Nuvance Health | 42 mi |
| Neurologic Stem Cell Treatment Study | N/A | MD Stem Cells | 45 mi |